NEXGEL CEO sells 6,000 shares in open market

Accepted by SEC EDGAR 06/09/2026 - 07:17 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

NEXGEL, INC. Chief Executive Officer Adam R. Levy reported open-market sales of company common stock. He sold 3,000 shares at $0.5936 per share on June 4 and 3,000 shares at $0.5470 per share on June 8. After these transactions, he directly holds 336,692 shares of NEXGEL common stock, indicating he retained the vast majority of his position.

Insider Trade Summary

Net Seller: 6,000 shares

Net Sell 2 txns

Insider Levy Adam R.

Role Chief Executive Officer

Sold 6,000 shs ($3K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,000	$0.547	$2K
Sale	Common Stock	3,000	$0.5936	$2K

Holdings After Transaction: Common Stock — 336,692 shares (Direct)

Footnotes (2)

F1. The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5936 per share.
F2. The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5470 per share.

Key Figures

Shares sold June 4: 3,000 shares at $0.5936 Shares sold June 8: 3,000 shares at $0.5470 Total shares sold: 6,000 shares +2 more

5 metrics

Shares sold June 4 3,000 shares at $0.5936 Open-market sale of NEXGEL common stock

Shares sold June 8 3,000 shares at $0.5470 Open-market sale of NEXGEL common stock

Total shares sold 6,000 shares Two non-derivative open-market sales

Shares held after transactions 336,692 shares Direct ownership of NEXGEL common stock

Net buy/sell direction Net sale of 6,000 shares Form 4 transaction summary

Key Terms

open-market sale, non-derivative, Common Stock

3 terms

open-market sale financial

"The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5936 per share."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"transaction_type": "non-derivative""

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did NEXGEL (NXGL) report for CEO Adam R. Levy?

NEXGEL reported that CEO Adam R. Levy sold a total of 6,000 shares of common stock in two open-market transactions. These non-derivative sales were disclosed on a Form 4 and involved small portions of his overall direct holdings.

How many NEXGEL (NXGL) shares did the CEO sell and at what prices?

Adam R. Levy sold 3,000 NEXGEL common shares at $0.5936 per share and another 3,000 shares at $0.5470 per share. Both transactions were classified as open-market sales of non-derivative common stock according to the Form 4 filing.

What are Adam R. Levy’s NEXGEL (NXGL) holdings after the reported sales?

Following the two open-market sales totaling 6,000 shares, Adam R. Levy directly holds 336,692 shares of NEXGEL common stock. This shows that, despite the sales, he maintains a substantial remaining equity position in the company.

Were the recent NEXGEL (NXGL) CEO transactions derivative exercises or simple stock sales?

The reported NEXGEL CEO transactions were simple stock sales, not derivative exercises. Both entries involve non-derivative common stock, coded as open-market sales, with no associated option exercise or conversion prices disclosed in the Form 4 data.

Do the NEXGEL (NXGL) CEO’s Form 4 footnotes change how the sales are interpreted?

The footnotes confirm that Adam R. Levy himself sold all 3,000 shares in each transaction at the stated prices in the open market. They do not reference trusts, LLCs, or lack of voting power, so the sales are attributed directly to him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Adam R.

(Last)

(First)

(Middle)

C/O NEXGEL, INC.

2150 CABOT BLVD, WEST, SUITE B

(Street)

LANGHORNE

PENNSYLVANIA

19047

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/04/2026		S		3,000	D	$0.5936⁽¹⁾	339,692	D
Common Stock	06/08/2026		S		3,000	D	$0.547⁽²⁾	336,692	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5936 per share.

2. The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5470 per share.

	/s/ Adam R. Levy	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR